| Autor: |
Revers, Leigh, Furczon, Eva |
| Zdroj: |
Canadian Pharmacists Journal; Jul/Aug2010, Vol. 143 Issue 4, p184-191, 8p, 1 Diagram, 1 Chart |
| Abstrakt: |
The article focuses on biologics as a class of protein-based therapeutics that are produced from living organisms. It talks about the challenges associated with subsequent entry biologics (SEB) and explores the diversity of biologics. It explains the differences of the two and it discusses the implications of such differences for pharmacists. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
